U.S. market Closed. Opens in 1 hour 5 minutes

CVKD | Cadrenal Therapeutics, Inc. Common Stock Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-31
RevenueN/AN/A
Cost of Revenue1.98K1.27K
Gross Profit-1.98K-1.27K
Operating Expenses7.63M2.70M
Selling, General & Admin3.55M2.31M
Research & Development4.08M392.86K
Other Operating Expenses1.98KN/A
Operating Income-7.63M-2.70M
Other Expenses / Income-724.25K-4.01M
Before Tax Income-8.36M-6.71M
Income Tax Expenses-165.91K4.00
Net Income-8.36M-6.71M
Interest Expenses17.10K107.11K
Basic Shares Outstanding868.18K775.64K
Diluted Shares Outstanding868.18K775.64K
EBITDA-7.63M-2.70M
EBITDA Margin0.00%0.00%
EBIT-8.51M-6.61M
EBIT Margin0.00%0.00%
Financial Year End2023-12-312022-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙